Does Nox2 Overactivate in Children with Nonalcoholic Fatty Liver Disease?

Antioxid Redox Signal. 2019 Apr 1;30(10):1325-1330. doi: 10.1089/ars.2018.7596. Epub 2018 Aug 17.

Abstract

It is unknown whether nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 (Nox2) activation is early associated with endotoxemia and liver damage in nonalcoholic fatty liver disease (NAFLD). To address this issue, we evaluated Nox2 activation, oxidative stress, gut permeability, and lipopolysaccharide (LPS) serum levels in 67 children with biopsy-proven NAFLD and 73 controls. Compared with controls, NAFLD patients had higher Nox2 activity, isoprostane, zonulin, and LPS levels. Multivariate linear regression analysis showed that triglycerides, high-density lipoprotein (HDL), homeostatic model assessment-estimated insulin resistance (HOMA-IR), LPS, and isoprostanes were independently associated with Nox2-derivative peptide (sNox2-dp) levels. Within the NAFLD group, patients with nonalcoholic steatohepatitis (NASH) had significant higher levels of sNox2-dp, isoprostanes, LPS, triglycerides, HOMA-IR, fasting glucose and insulin, and lower HDL than those without NASH. Furthermore, sNox2-dp levels were linearly associated with the histological grading of steatosis, inflammation, ballooning, fibrosis, and NAFLD activity score. This study provides evidence that children with NAFLD have Nox2 overactivation compared with controls and significant association with the degree of liver damage. The close relationship between Nox2 and LPS serum levels leads to hypothesize a potential role for gut-derived LPS in eliciting systemic Nox2 activation.

Keywords: NADPH oxidase; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; oxidative stress.

MeSH terms

  • Adolescent
  • Case-Control Studies
  • Child
  • Cross-Sectional Studies
  • Enzyme Activation
  • Female
  • Haptoglobins
  • Humans
  • Isoprostanes / blood*
  • Lipopolysaccharides / blood*
  • Male
  • NADPH Oxidase 2 / metabolism*
  • Non-alcoholic Fatty Liver Disease / metabolism
  • Non-alcoholic Fatty Liver Disease / pathology*
  • Oxidative Stress
  • Protein Precursors / blood*
  • Regression Analysis
  • Severity of Illness Index

Substances

  • Haptoglobins
  • Isoprostanes
  • Lipopolysaccharides
  • Protein Precursors
  • zonulin
  • CYBB protein, human
  • NADPH Oxidase 2